- Home
- XNCR vs NKTR Comparison
XNCR vs NKTR Comparison
Compare XNCR & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- NKTR
- Stock Information
- Founded
- XNCR 1997
- NKTR 1990
- Country
- XNCR United States
- NKTR United States
- Employees
- XNCR N/A
- NKTR N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- XNCR Health Care
- NKTR Health Care
- Exchange
- XNCR Nasdaq
- NKTR Nasdaq
- Market Cap
- XNCR 547.8M
- NKTR 558.0M
- IPO Year
- XNCR 2013
- NKTR 1994
- Fundamental
- Price
- XNCR $8.62
- NKTR $47.34
- Analyst Decision
- XNCR Buy
- NKTR Strong Buy
- Analyst Count
- XNCR 10
- NKTR 6
- Target Price
- XNCR $23.33
- NKTR $81.67
- AVG Volume (30 Days)
- XNCR 726.1K
- NKTR 1.1M
- Earning Date
- XNCR 11-05-2025
- NKTR 11-06-2025
- Dividend Yield
- XNCR N/A
- NKTR N/A
- EPS Growth
- XNCR N/A
- NKTR N/A
- EPS
- XNCR N/A
- NKTR N/A
- Revenue
- XNCR $146,929,000.00
- NKTR $74,934,000.00
- Revenue This Year
- XNCR $22.06
- NKTR N/A
- Revenue Next Year
- XNCR N/A
- NKTR N/A
- P/E Ratio
- XNCR N/A
- NKTR N/A
- Revenue Growth
- XNCR N/A
- NKTR N/A
- 52 Week Low
- XNCR $6.92
- NKTR $6.48
- 52 Week High
- XNCR $27.24
- NKTR $50.00
- Technical
- Relative Strength Index (RSI)
- XNCR 55.91
- NKTR 83.16
- Support Level
- XNCR $8.25
- NKTR $42.12
- Resistance Level
- XNCR $8.73
- NKTR $50.53
- Average True Range (ATR)
- XNCR 0.37
- NKTR 3.22
- MACD
- XNCR 0.06
- NKTR 1.77
- Stochastic Oscillator
- XNCR 69.03
- NKTR 86.23
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.